NEW DELHI -- Two Indian companies have applied for emergency approval of their COVID-19 vaccine candidates in a country that is the second-worst hit by the coronavirus pandemic, days after U.S. drugmaker Pfizer did the same.
Pharmaceuticals
2 Indian drugmakers seek approval for COVID-19 vaccines
Move follows Pfizer application, with first licensing possible in a few weeks
